# Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus

> **NCT04344379** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 122 (actual)

## Conditions studied

- SARS-CoV-2 Infection

## Interventions

- **DRUG:** hydroxychloroquine
- **DRUG:** azithromycin
- **DRUG:** hydroxychloroquine placebo

## Key facts

- **NCT ID:** NCT04344379
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-17
- **Primary completion:** 2020-06-18
- **Final completion:** 2020-06-18
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2025-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04344379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04344379, "Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT04344379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*